JJCV2015-01.doc.docx



CURRICULUM VITAEDate Prepared:August 28, 2020Name: John A. Johnson, Jr., D.O.LICENSURE and CERTIFICATION:2018 – PresentBoard Certified Allergy-Immunology2018 – Present Massachusetts Medical License, Unrestricted, 2660752016 – PresentBoard Certified Internal Medicine2016 – PresentOhio Medical License, UnrestrictedWORK EXPERIENCE:05/2020 – PresentSpeaker Bureau for MepolizumabGlaxoSmithKlineBrentford, UK06/2019 – PresentSpeaker Bureau for BenralizumabAstraZenecaCambridge, UK04/2019 – 03/2020Attending AllergistNew England Food Allergy Treatment Center - BostonQuincy, MA08/2018 - PresentAttending Allergist-ImmunologistAllergy & Asthma Centers of Cape CodFalmouth, MA02/2019 – 01/2020 Hospitalist MedicineTobey Hospital/Charlton-Memorial Hospital/St. Luke’s HospitalWareham, MA07/2018 – PresentHospitalistCape Cod HospitalHyannis, MA12/2016 – 5/2019 Hospitalist MedicineAshtabula County Medical CenterCleveland Clinic FoundationCleveland, OHPOST-DOCTORAL TRAINING:07/2017-06/2018Chief, Clinical FellowPediatric & Adult Allergy/Immunology FellowshipUniversity Hospitals of ClevelandCase Western Reserve University – School of MedicineCleveland, OH07/2016 – 07/2018Ohio Clinical Research Associates Post-Doctoral Fellow and Sub-Investigator07/2016 – 06/2017Clinical FellowPediatric & Adult Allergy/Immunology FellowshipUniversity Hospitals of ClevelandCase Western Reserve University – School of MedicineCleveland, OH07/2014 – 06/2016ResidentInternal Medicine ResidencySaint Vincent HospitalUniversity of Massachusetts Medical SchoolWorcester, MA07/2013 – 07/2014InternInternal Medicine ResidencySaint Vincent HospitalUniversity of Massachusetts Medical SchoolWorcester, MADOCTORAL TRAINING:08/2009 – 05/2013College of Osteopathic Medicine, University of New EnglandBiddeford, MEDoctor of Osteopathic MedicineStudent Trustee - Elect, Board of Trustees, Univ. of New EnglandClass President – Elect 4 years, Class of 2013PRE-DOCTORAL TRAINING08/2002 - 06/2006 Syracuse UniversitySyracuse, NYB.S., Magna Cum Laude, Majors in Biology & PsychologyHonors ProgramHONORS AND AWARDS:2017Commendation from the State of New Hampshire Governor for Advancing the Field of Allergy & Immunology 2016 University Hospitals of Cleveland Graduate Medical Education (GME) Innovation Award from the ACGME CLER grant2016 Lake Erie College of Osteopathic Medicine Research Support Grant 20162012Family Medicine Education Consortium scholarship. 2006 Allport Scholar Award2006Allport Award for Excellence in Applied Psychology2006 Academic Achievement Award in Biology2005 - 2006 President and Co-founder of Beta Beta Beta National Biological Honor Society2003American Heart Association Research Fellowship (1 of 8 undergraduate students in the Northeast U.S. selected)PROFESSIONAL MEMBERSHIPS:2016 -Society for Pediatric Dermatology2016 -American Academy of Allergy, Asthma, and Immunology2016 -American College of Allergy, Asthma, and Immunology2016 -American Association of Immunologists2016 -Clinical Immunology Society2009 -American Osteopathic Association2005 - 2008American Heart Association2005 - 2008American Lung AssociationBOOK CHAPTERS:Johnson J, Abraham T, Sandhu M, Jhaveri D, Hostoffer R, Sher T. “Differential diagnosis of asthma.” HYPERLINK "" \t "_blank" Allergy and Asthma: The Basics to Best Practices. Edited by?Massoud Mahmoudi. Published February 18, 2019.INVITED PRESENTATIONS:LocalJohnson JA. Update on Asthma. Department of Medicine. Cape Cod Hospital. June 20, 2019.Johnson JA. Peanut Allergy & Oral Immunotherapy. Department of Pediatrics. Cape Cod Hospital. November 28, 2018.RegionalJohnson JA. Cough: It’s Not All It’s Hacked Up To Be. 2018 UNE COM Reunion and CME Event. October 20, 2018.Abraham T, Johnson JA, Sandhu M, Jhaveri D, Hostoffer R. Osteopathic Focused Modules for Allergy/Immunology. 2017 UHOC Research Symposium.Li L, Johnson JA, Peppers B, Tcheurekdjian H, Hostoffer R. Common Variable Immunodeficiency with Angiosarcoma Associated with Hyperammonia Secondary to High Dose IVIG Infusion. 2017 UHOC Research Symposium.Abraham T, Johnson JA, Sandhu M. 4th Annual Grand Rounds: Penicillin Desensitization for the Treatment of Secondary Syphilis in a Penicillin Allergic Pregnant Female. Cleveland Academy of Osteopathic Medicine 52nd Annual January Seminar 2017. Johnson JA. Hyper-IgE Syndrome. Morbidity & Mortality Grand Rounds. Department of Internal Medicine, Cleveland Medical Center. June 9th, 2017.NationalJohnson JA, Abraham T, Sandhu M, Peppers B, Lyman B, Knozer K, Romanello G, Hostoffer R. Common Misconceptions in the Recognition and Treatment of Anaphylaxis in Community Hospital Based Medical Professionals. Oral presentation at ACAAI’s 2017 Annual Scientific Meeting, October 29th, 2017 in Boston, Massachusetts.Johnson JA. Anaphylaxis; The Unusual Types. American College of Osteopathic Pediatricians 2017 Spring Conference, Louisville, KY.InternationalJohnson JA. Anaphylaxis. WorldBoston: A World Affairs Council. Global Health: Building Country Capacity Conference, Atkinson, NH.PUBLICATIONS: Graven K, Joseph N, Johnson J, Abboud H, Fulton S, Yasmin M, Hostoffer R. A Pregnant Patient with Post-Vaccination Demyelination after MMR Vaccination. Accepted for publication in the International Journal of MS Care in June 2019. Mansour D, Johnson J, Peppers B, Hostoffer R. Hyper IgM transitioning to Agammaglobulinemia in a Patient with PI3KR1 Mutation. In progress.Schend J, McGarry D, Johnson J, Hostoffer R. Common variable immunodeficiency associated with stiff-person syndrome. Ann Allergy Asthma Immunol. 2018 Jan 30.Johnson JA, Peppers BP, Tcheurekdjian H, Hostoffer R. Hypogammaglobulinemia with Specific Antibody Response Deficiency Presenting with Recurrent Ascending Cholangitis. In progress.Wu SS, Sandhu M, Johnson JA, Tcheurekdjian H, Hostoffer R. Green Tea Anaphylaxis Case Series. In progress.Wu SS, Johnson JA, Tcheurekdjian H, Hostoffer R. A Case of Green Tea (Camellia sinensis) Imbibement Causing Possible Anaphylaxis. Ann Allergy Asthma Immunol. 2017 Jun; 118(6):747-748.Cundiff NM, Johnson JA, Tcheurekdjian H, Hostoffer R. Case Series of Transient Humoral Immunodeficiency with Progression to Auto-inflammatory Disorder in Adolescents. In progress.Li L, Johnson JA, Peppers B, Tcheurekdjian H, Hostoffer R. Common Variable Immunodeficiency with Angiosarcoma Associated with Hyperammonia Secondary to High Dose IVIG Infusion. In progress.Giraldi E, Johnson JA, Tcheurekdjian H, Hostoffer R. Idiopathic Avascular Necrosis Associated with Humoral Deficiency. Ann Allergy Asthma Immunol. 2017 Apr; 118(4):506-507.Abraham T, Sandhu M, Johnson JA. AMCNO Pollen Line – 2016 Recap. The Academy of Medicine of Cleveland and Northern Ohio. 2016 Nov/Dec; 101(6):1-2.Doll RJ, Johnson JA, Abraham T, Sandhu M, Hostoffer R. Peanut Desensitization: A Review of the Literature. eJournal of the American College of Osteopathic Pediatricians. Fall 2016 Issue.Doll RJ, Johnson JA, Tcheurekdjian H, Hostoffer R. IgE Mediated Anaphylactic Shock Caused by?Pumpkin Seed in an Adult. Ann Allergy Asthma Immunol. Doll RJ, Johnson JA, Tcheurekdjian H, Hostoffer R. Common Variable Immune Deficiency Associated with Pemphigoid. Ann Allergy Asthma Immunol. 2017 Jan; 118(1):122.Johnson JA, Frith JA, Casselman J, Saad A, Tcheurekdjian H, Hostoffer R. Thromboembolic stroke: A Sequela of Hymenoptera Venom-induced Anaphylaxis. Ann Allergy Asthma Immunol. 2016 Mar; 116(3):262-4.Sales VL, Engelmayr GC, Gottlieb D, Johnson, Jr JA, Gao J, Wang Y, Sacks MS, Mayer, Jr JE. “Protein Precoating of Elastomeric Tissue-Engineering Scaffolds: Extracellular Matrix Formation and Phenotypic Changes of Circulating Endothelial Progenitor Cells.” Circulation Res. 2006; Vol. 99; Issue 5; 35Sales, VL, Mettler, BA, Lopez-Ilasaca, M, Johnson, Jr JA, Mayer Jr., JE. “Endothelial Progenitor and Mesenchymal Stem Cell-Derived Cells Persist in Tissue-engineered Patch in Vivo: Application of Green and Red Fluorescent Protein–Expressing Retroviral Vector.” Tissue Engineering 2007 Mar; 13(3): 525-535Sales VL, Mettler BA, Engelmayr, Jr G, Johnson, Jr JA, Sacks MS, Mayer Jr, JE. “Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds.” Circulation, 2006 Jul 4; 114(1 Suppl): I 193-199.POSTER PRESENTATIONS AND ABSTRACTS:Li L, Johnson JA, Michaud C, Tcheurekdjian H, Hostoffer R. Common Variable Immunodeficiency with Angiosarcoma Associated with Hyperammonia Secondary to High Dose IVIG Infusion. The Journal of Allergy & Clinical Immunology, 2017 Feb; 139(2):AB22. Li L, Johnson JA, Michaud C, Tcheurekdjian H, Hostoffer R. Common Variable Immunodeficiency with Angiosarcoma Associated with Hyperammonia Secondary to High Dose IVIG Infusion. 2017 AAAAI Annual Meeting, Atlanta, GA.Cundiff NM, Johnson JA, Tcheurekdjian H, Hostoffer R. Case Series of Transient Humoral Immunodeficiency with Progression to Auto-inflammatory Disorder in Adolescents. American College of Osteopathic Pediatricians 2017 Spring Conference, Louisville, KY.Johnson JA, Peppers BP, Tcheurekdjian H, Hostoffer R. Common Variable Immunodeficiency Presenting with Recurrent Ascending Cholangitis. Poster Presentation ACAAI Fall 2016. Johnson JA, Saad A, Tcheurekdjian H, Hostoffer R. An Itch for Berries: Blackberry-induced Urticaria. Eastern Allergy Conference, Palm Beach, FL in May 2015. Bartley A, Patibandla B, Johnson JA. “Gastroesophageal Reflux Disease and Length of Hospitalization in Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.” 79th Annual Scientific Meeting in Philadelphia, PA. American College of Gastroenterology. Scheduled presentation October 19th, 2014.Sales VL,?Johnson, Jr JA,?Hoganson DM ,?Delmo?Walter EM,?Kim G,?Martin DP,?Mettler BA,? Mayer, Jr. JE. “Mesenchymal Stem Cells And Endothelial Progenitor In Tissue Engineering Of Heart Valves Can Respond Distinctively And Selectively To Biomechanical Signals.” Presented at the Society for Heart Valve Disease 2009 in Berlin, Germany.Sales VL, Mettler BA, Engelmayr, Jr G, Johnson, Jr JA, Sacks MS, Mayer Jr, JE. “Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds.” Oral presentation at American Heart Association Scientific Sessions 2005 in Dallas, Texas, November 13-16. Circulation, 2006 Jul 4; 114(1 Suppl): I 193-199.Sales VL, Mettler BA, Lopez-Ilasaca M, Johnson, Jr JA, Mayer, Jr JE. “Retroviral GFP and RFP Transduction of Progenitor cells: Potential Use in Cardiovascular Tissue Engineering.” Poster presentation at the Tissue Engineering Society International and European Tissue Engineering, Lausanne, Switzerland, October 10-13th 2004. Published in the Meeting Proceedings, page 269.Sales VL, Mettler BA, Engelmayr, Jr G, Johnson, Jr JA, Sacks MS, Mayer Jr, JE. "Circulating endothelial progenitor cells elicit matrix remodeling in response to TGF-? 1 in tissue-engineered scaffolds." Oral Presentation at the Tissue Engineering Society International and European Tissue Engineering Conference, Lausanne, Switzerland, October 10-13th 2004. Published in the Meeting Proceedings, page 42.Mettler BA, Sales VL, Farber M, Rabkin-Aikawa E, Wylie-Sears J, Johnson, Jr JA, Stucken CL, Martin DP, Bischoff J, Schoen FJ, Mayer, Jr JE. “Systematic Control of Structure for Tissue-engineered Heart Valves: A Pursuit of Clinical Application.” Oral presentation at the International Heart Valve Conference, Florence, Italy, September 15-18, 2004.QUALITY IMPROVEMENT STUDIES:Johnson JA, Abraham T, Sandhu M, Peppers B, Lyman B, Knozer K, Romanello G, Hostoffer R. Common Misconceptions in the Recognition and Treatment of Anaphylaxis in Community Hospital Based Medical Professionals. Accepted for oral presentation at ACAAI’s 2017 Annual Scientific Meeting, October 29th, 2017 in Boston, Massachusetts.CLINICAL TRIALS:Sub-Investigator:Study 017Bivigam? in adults with primary immunodeficiency.A multicenter, non-interventional, observational, prospective study to assess hypotension in patients with primary immune deficiency disease treated with Bivigam? (Human 10%) or other commercial Human 10% immune globulin (intravenous) (IGIV) products during infusion and up to 72 hours post infusion?Study 994Bivigam? in children with primary immunodeficiency.A Phase IV, Multicenter, Openlabel Study to Evaluate the Safety and Pharmacokinetics of Bivigam? in Primary Immune Deficiency Disorders in Subjects Aged 2 to 16?GAM10-08Prospective, Double-blind, Randomized, Placebo-Controlled Phase III Study Evaluating Efficacy and Safety of Octagam 10% in Patients with Dermatomyositis ("ProDERM study"). Performed eligibility screening of patients. Withdrew from study prior to enrollment.GAM5-28Postmarketing Requirement Non-Interventional 2-armed Study to Evaluate the Safety of Octagam? Immune Globulin Intravenous (Human) 5% Liquid Preparation, With a Special Emphasis on Monitoring, Analysis and Reporting of Thromboembolic Events ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download